Table 1.

NSABP FB-7: patient characteristics by randomized arm

	Arm 1, n = 42	Arm 2, n = 42	Arm 3, n = 42
Age, years
Median	50.0	56.0	50.0
Range	33–71	29–71	31–77
Performance status
ECOG 0	42 (100%)	42 (100%)	41 (97.6%)
ECOG 1	0	0	1 (2.4%)
Tumor stage
IIB	18 (42.8%)	19 (45.2%)	20 (47.6%)
III	21 (50%)	20 (47.6%)	22 (52.3%)
Missing	3 (7.1%)	3 (7.1%)	0
Inflammatory	4(9.5%)	7(16.7%)	4(9.5%)
Menopausal status
Pre	25 (60%)	16 (38%)	23 (55%)
Post	17 (40%)	26 (62%)	19 (45%)
Hormone receptor
Positive	28 (67%)	29 (69%)	23 (55%)
Negative	14 (33%)	13 (31%)	19 (45%)
Clinical tumor size
Mean, cm	4.50	5.04	4.72
Median, cm	3.70	5.50	5.00
Range, cm	0.0–18.0	0.0–10.0	0.0–9.0
HER2
IHC	24 (57.1%)	24 (57.1%)	25 (59.5%)
ISH	15 (35.7%)	12 (28.6%)	11 (26.2%)
IHC and ISH	3 (7.1%)	6 (14.3%)	6 (14.3%)